ORGANOGENESIS HOLDINGS INC. financials

ORGO CIK 0001661181

Source: EDGAR filings · Built 2026-06-02T03:45:23Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -25.63M 3.10M 6.07M -9.24M 28.13M -14.64M
EBITDA 59.97M 12.34M 22.97M 28.15M 82.95M 34.88M
Working Capital 262.06M 208.46M 144.53M 147.59M 144.27M 106.13M
Net Debt -11.54M 4.67M 15.84M 21.79M 19.01M 667.00K
Gross Margin 75.99% 75.42% 76.71% 75.56% 74.19%
Operating Margin 7.92% -0.27% 2.89% 4.95% 15.45% 7.89%
Net Margin 6.56% 0.18% 1.14% 3.44% 20.16% 5.09%
Return on Equity (ROE) 12.34% 0.33% 1.77% 5.85% 39.03% 12.15%
Return on Assets (ROA) 6.19% 0.17% 1.07% 3.46% 21.25% 5.94%
Current Ratio 3.62× 3.69× 2.80× 2.97× 2.74× 2.56×
Debt-to-Equity 0.27× 0.53× 0.43× 0.47× 0.55× 0.60×
Effective Tax Rate 21.16% 130.67% 52.42% 23.42% -49.32% 2.98%
Cash Conversion Ratio -0.28× 16.50× 6.25× 1.60× 0.66× 0.32×
Accruals Ratio 0.08× -0.03× -0.06× -0.02× 0.07× 0.04×
SBC % of Revenue 2.36% 2.19% 2.08% 1.45% 0.83% 0.49%
CapEx Coverage -0.67× 1.28× 1.24× 0.73× 1.83× 0.27×
Free Cash Flow Per Share $-0.20 $0.02 $0.05 $-0.07 $0.21 $-0.13

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 34.53× 102.25× 22.42× 13.20× 50.20×
P/FCF 136.17× 89.50× 43.92×
FCF Yield 0.73% 1.12% 2.28%
EV / EBITDA 10.77× 32.98× 24.07× 13.29× 14.56× 27.59×
P/S 1.17× 0.83× 1.24× 0.78× 2.54× 2.84×
P/B 2.19× 1.53× 1.93× 1.33× 4.93× 6.78×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 564.17M 482.04M 433.14M 450.89M 467.36M 338.30M
Cost of Revenue 115.74M 106.48M 105.02M 114.20M 87.32M
Gross Profit 366.30M 326.66M 345.87M 353.16M 250.98M
Research and Development Expense 44.54M 50.27M 44.38M 39.76M 30.74M 20.09M
Selling, General and Administrative Expense 326.24M 294.51M 269.75M 283.81M 250.20M 204.19M
Operating Expenses 519.48M 483.33M 420.62M 323.57M 280.94M 224.28M
Operating Income (Loss) 44.69M -1.28M 12.53M 22.30M 72.22M 26.70M
Income Tax Expense (Benefit) 9.94M -3.67M 5.45M 4.75M -31.12M 530.00K
Net Income (Loss) Attributable to Parent 37.03M 861.00K 4.95M 15.53M 94.20M 17.23M
Earnings Per Share, Basic $0.16 $-0.01 $0.04 $0.12 $0.73 $0.16
Weighted Average Number of Shares Outstanding, Basic 126.74M 131.67M 131.23M 130.07M 128.33M 107.74M
Earnings Per Share, Diluted $0.15 $-0.01 $0.04 $0.12 $0.70 $0.15
Weighted Average Number of Shares Outstanding, Diluted 130.25M 131.67M 132.75M 132.38M 133.66M 111.36M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 93.68M 135.57M 103.84M 102.48M 113.93M 84.39M
Assets, Current 362.19M 285.94M 225.04M 222.61M 226.98M 174.34M
Assets 598.73M 497.89M 460.02M 449.36M 443.26M 290.22M
Long-term Debt 66.56M 71.25M 74.06M 70.00M
Liabilities, Current 100.12M 77.48M 80.51M 75.02M 82.70M 68.22M
Liabilities 164.81M 112.57M 181.36M 183.69M 201.92M 148.41M
Stockholders' Equity Attributable to Parent 300.13M 262.90M 278.66M 265.67M 241.34M 141.81M
Common Stock, Shares, Outstanding 126.95M 125.73M 131.32M 130.92M 128.68M 127.73M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -10.31M 14.21M 30.92M 24.86M 61.98M 5.47M
Payments to Acquire Property, Plant, and Equipment 14.15M 10.03M 24.36M 33.90M 31.22M 17.68M
Net Cash Provided by (Used in) Investing Activities -14.15M -10.03M -24.36M -33.90M -31.22M -23.50M
Payments for Repurchase of Common Stock 25.48M 0 0
Net Cash Provided by (Used in) Financing Activities -17.36M 27.64M -5.50M -2.20M -1.04M 42.47M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ORGO CIK 0001661181), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CLDT

Chatham Lodging Trust

LLY

ELI LILLY & Co

SYRE

SPYRE THERAPEUTICS, INC.